FIELD: medicine, immunology. SUBSTANCE: invention relates to preparing the preparation based on recombinant human lymphotoxin that retains all main biological properties. Preparation has the following components at ratio, wt. -%: recombinant lymphotoxin 0.05-0.1; sodium acetate 0.08-0.1; sodium chloride 1.5-1.8; polyglucin 1.3-1.5, and distilled water - the rest. EFFECT: enhanced effectiveness of preparation. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MANUFACTURING HUMAN RECOMBINATION LYMPHOTOXIN | 1992 |
|
RU2039823C1 |
GENETIC-ENGINEERING GAMMA-INTERFERON PREPARATION | 1994 |
|
RU2077336C1 |
METHOD OF PREPARING POLYPEPTIDE SHOWING HUMAN LYMPHOTOXIN PROPERTY | 1992 |
|
RU2048521C1 |
RECOMBINANT PLASMID DNA P-L-T21 CODING POLYPEPTIDE | 0 |
|
SU1709731A1 |
RECOMBINANT STRAIN OF SALMONELLA MINNESOTA - A PRODUCER OF PLAGUE MICROBE CAPSULE ANTIGENE | 1992 |
|
RU2046145C1 |
RECOMBINANT PLASMID DNA "pДТИ-23", METHOD OF PREPARING RECOMBINANT PLASMID DNA "pДТИ-23" AND STRAIN OF BACTERIUM ESCHERICHIA COLI CONTAINING RECOMBINANT PLASMID DNA "pДТИ-23" - A PRODUCER OF THE FUSED PROTEIN DTI-2 | 1993 |
|
RU2077585C1 |
RECOMBINANT PLASMID DNA PTHY 315 ENCODING HYBRID PROTEIN TUMOR NECROSIS α-FACTOR - THYMOSIN-a | 1992 |
|
RU2077586C1 |
METHOD OF PREPARING THE SOLUBLE ANTIGEN-BASE VACCINE FOR TICK-BORNE ENCEPHALITIS CONTROL | 1994 |
|
RU2084242C1 |
PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
PREPARATION SHOWING IMMUNOMODULATING ACTIVITY | 1995 |
|
RU2102988C1 |
Authors
Dates
1997-09-27—Published
1994-12-06—Filed